InnovexLab Respiratory panel
Respiratory viruses, bacteria and Pneumocystis identified directly from respiratory swabs, with a Basic Flu option and a reflex resistance panel.
General medical information for education only, not medical advice. Targets as listed on InnovexLab’s requisition forms (respiratory requisition form). Detection of a target does not by itself establish infection or determine treatment; results are interpreted by the ordering clinician with the clinical picture and, where indicated, culture and susceptibility testing.
When to consider testing
Symptomatic respiratory illness (cough, fever, sore throat, shortness of breath), particularly clusters of cases in a facility where results guide isolation, cohorting and antiviral or antibiotic decisions.
Interpretation
A viral result can support withholding antibiotics. Bacteria detected in upper-airway specimens may reflect colonization.
Targets (48)
Select a target for its clinical summary, symptoms, resistance and treatment considerations.
Viruses (23)
- AdenovirusDNA viruses with many types: some cause respiratory illness and conjunctivitis, enteric types 40 and 41 cause gastroenteritis in children.
- BocavirusA small DNA virus found in respiratory specimens from young children, often alongside other viruses.
- Coronavirus 229ECommon coronaviruses that circulate every year; distinct from SARS-CoV-2.
- Coronavirus HKU1Common coronaviruses that circulate every year; distinct from SARS-CoV-2.
- Coronavirus NL63Common coronaviruses that circulate every year; distinct from SARS-CoV-2.
- Coronavirus OC43Common coronaviruses that circulate every year; distinct from SARS-CoV-2.
- EnterovirusA large group of RNA viruses, spread by the fecal-oral and respiratory routes, with a summer and fall peak.
- Influenza ARNA viruses that cause seasonal epidemics.
- Influenza A/H1-2009RNA viruses that cause seasonal epidemics.
- Influenza A/H3RNA viruses that cause seasonal epidemics.
- Influenza BRNA viruses that cause seasonal epidemics.
- Influenza CRNA viruses that cause seasonal epidemics.
- Metapneumovirus A & BAn RNA virus related to RSV, causing late-winter and spring respiratory illness.
- MERS coronavirusCoronaviruses that caused the 2003 SARS outbreak and Middle East respiratory syndrome.
- Parainfluenza virus 1RNA viruses causing respiratory infection; types 1 and 2 cause croup in children and type 3 causes bronchiolitis and pneumonia.
- Parainfluenza virus 2RNA viruses causing respiratory infection; types 1 and 2 cause croup in children and type 3 causes bronchiolitis and pneumonia.
- Parainfluenza virus 3RNA viruses causing respiratory infection; types 1 and 2 cause croup in children and type 3 causes bronchiolitis and pneumonia.
- Parainfluenza virus 4RNA viruses causing respiratory infection; types 1 and 2 cause croup in children and type 3 causes bronchiolitis and pneumonia.
- ParechovirusRNA viruses related to enteroviruses; important in young infants.
- Respiratory syncytial virus AAn RNA virus causing winter respiratory illness; serious in infants, older adults and people with heart or lung disease.
- Respiratory syncytial virus BAn RNA virus causing winter respiratory illness; serious in infants, older adults and people with heart or lung disease.
- RhinovirusThe most frequent cause of the common cold; closely related to enteroviruses.
- SARS coronavirusCoronaviruses that caused the 2003 SARS outbreak and Middle East respiratory syndrome.
Bacteria (17)
- Bordetella pertussisSmall Gram-negative coccobacilli.
- Bordetella parapertussisSmall Gram-negative coccobacilli.
- Bordetella holmesiiSmall Gram-negative coccobacilli.
- Chlamydia (Chlamydophila) pneumoniaeAn obligate intracellular bacterium spread by respiratory droplets.
- Coxiella burnetiiAn intracellular bacterium from livestock and their birth products; it cannot be seen on routine Gram stain.
- Haemophilus influenzaeA small Gram-negative coccobacillus of the upper airway.
- Haemophilus influenzae type bA small Gram-negative coccobacillus of the upper airway.
- Klebsiella pneumoniaeAn encapsulated gut organism and a major cause of healthcare-associated infection, frequently carrying resistance genes.
- Legionella pneumophilaGram-negative rods from water systems (L.
- Legionella longbeachaeGram-negative rods from water systems (L.
- Moraxella catarrhalisA Gram-negative diplococcus of the upper airway.
- Mycoplasma pneumoniaeA small bacterium without a cell wall that spreads by respiratory droplets, often in households, schools and institutions.
- Staphylococcus aureusA Gram-positive coccus in clusters carried on the skin and in the nose of many people, and a major cause of skin, soft-tissue and invasive infection.
- Streptococcus pneumoniaeA Gram-positive lancet-shaped diplococcus colonizing the nasopharynx and the most common bacterial cause of community-acquired pneumonia.
- Group A StreptococcusA beta-hemolytic Gram-positive coccus in chains.
- Group B StreptococcusA Gram-positive coccus that colonizes the gut and genital tract.
- Group C and G StreptococcusBeta-hemolytic streptococci that cause infections resembling group A Streptococcus, particularly in older adults with comorbidities.
Fungi (1)
Basic Flu panel (4)
- Influenza ARNA viruses that cause seasonal epidemics.
- Influenza BRNA viruses that cause seasonal epidemics.
- Respiratory syncytial virus A/BAn RNA virus causing winter respiratory illness; serious in infants, older adults and people with heart or lung disease.
- SARS-CoV-2The coronavirus that causes COVID-19.
Reflex antibiotic-resistance genes (3)
Sources
- ATS / IDSA. Community-Acquired Pneumonia in Adults guideline.
- CDC. Influenza antiviral medications: summary for clinicians.
- CDC. Respiratory syncytial virus (RSV).
- CDC. COVID-19.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.